Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vertex Pharmaceuticals
Biotech
As pharma eyes shiny obesity drugs, Vertex tops orphan drug list
Vertex’s cystic fibrosis triple combo is the top orphan pipeline drug, amid shifting sentiments in the pharma industry for rare disease drugs.
Annalee Armstrong
Apr 24, 2024 12:01am
How Vertex became the VIP of Alpine's exclusive data room
Apr 23, 2024 11:19am
Vertex inches closer to acute pain market as FDA accepts VX-548
Apr 18, 2024 10:50am
Vertex pays $4.9 billion to hike Alpine’s immunology trail
Apr 10, 2024 5:30pm
Sionna adds $182M to extend pipeline, cash runway through 2026
Mar 6, 2024 8:00am
Latigo raises $135M to catch up to Vertex in chronic pain
Feb 14, 2024 5:00am